137 related articles for article (PubMed ID: 8314685)
1. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
2. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Pravastatin Multicenter Study Group II.
Arch Intern Med; 1993 Jun; 153(11):1321-9. PubMed ID: 8507122
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
Lewis JH; Mortensen ME; Zweig S; Fusco MJ; Medoff JR; Belder R;
Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
[TBL] [Abstract][Full Text] [Related]
4. [Pravastatin in patients with cardiac risk factors. Effects of pravastatin in patients with total serum cholesterol concentrations of 200 to 300 mg/dl (5.2 to 7.8 mmol/l) and two additional atherosclerosis risk factors. Pravastatin Multinational Study Group for Cardiac Risk Patients].
Fortschr Med; 1994 Feb; 112(5):57-64. PubMed ID: 8163252
[TBL] [Abstract][Full Text] [Related]
5. [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study].
Ferrari P; Weidmann P; Riesen WF; Martius F; Luban S; Pasotti E; Erne P; Fragiacomo C; Noseda G; Reutter F
Schweiz Med Wochenschr; 1993 Sep; 123(37):1736-41. PubMed ID: 8211024
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of once-daily versus twice-daily pravastatin in primary hypercholesterolemia.
Pan HY; DeVault AR; Brescia D; Willard DA
Clin Ther; 1991; 13(3):368-72. PubMed ID: 1954638
[TBL] [Abstract][Full Text] [Related]
7. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
Bays HE; Ose L; Fraser N; Tribble DL; Quinto K; Reyes R; Johnson-Levonas AO; Sapre A; Donahue SR;
Clin Ther; 2004 Nov; 26(11):1758-73. PubMed ID: 15639688
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and safety of low dose pravastatin in elderly hypertensive hypercholesterolemic subjects on antihypertensive therapy.
Chan P; Lee CB; Lin TS; Ko JT; Pan WH; Lee YS
Am J Hypertens; 1995 Nov; 8(11):1099-104. PubMed ID: 8554733
[TBL] [Abstract][Full Text] [Related]
9. The RED-LIP study--pravastatin in primary isolated hypercholesterolemia--an open, prospective, multicenter trial.
Sinzinger H; Pirich C
Wien Klin Wochenschr; 1994; 106(23):721-7. PubMed ID: 7856175
[TBL] [Abstract][Full Text] [Related]
10. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
[TBL] [Abstract][Full Text] [Related]
11. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
[TBL] [Abstract][Full Text] [Related]
12. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of primary hypercholesterolemia with pravastatin. A placebo-controlled trial].
Frederiksen SM; Larsen ML; Oxenbøll IB; Pindborg T; Haghfelt T
Ugeskr Laeger; 1993 Sep; 155(36):2794-9. PubMed ID: 8236548
[TBL] [Abstract][Full Text] [Related]
14. Pravastatin and risk factor modification in patients with moderate primary hypercholesterolaemia.
Morris R; Robinson G; Tilyard M; Gurr E
N Z Med J; 1996 Aug; 109(1028):319-22. PubMed ID: 8816723
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS
Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of pravastatin in hypertensive hypercholesterolaemic patients on antihypertensive drug therapy.
Celis H; Lijnen P; Fagard R; Staessen J; Thijs L; Amery A
J Hum Hypertens; 1994 Jul; 8(7):525-30. PubMed ID: 7932517
[TBL] [Abstract][Full Text] [Related]
17. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Strony J; Hoffman R; Hanson M; Veltri E
Clin Ther; 2008 Dec; 30(12):2280-97. PubMed ID: 19167588
[TBL] [Abstract][Full Text] [Related]
19. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety and, tolerability profiles and lipid-modifying efficacy of ezetimibe coadministered with ongoing simvastatin treatment: a multicenter, randomized, double-blind, placebo-controlled, 48-week extension study.
Masana L; Mata P; Gagné C; Sirah W; Cho M; Johnson-Levonas AO; Meehan A; Troxell JK; Gumbiner B;
Clin Ther; 2005 Feb; 27(2):174-84. PubMed ID: 15811480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
